Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer

被引：0
|
作者：
Conti, F. [1 ]
Corsetti, S. [1 ]
Viola, G. [1 ]
Sperduti, I. [1 ]
Carpano, S. [1 ]
Pizzuti, L. [1 ]
Foggi, P. [1 ]
Perri, P. [1 ]
Anza, M. [1 ]
Toglia, G. [1 ]
Lopez, M. [1 ]
机构：
[1] Regina Elena Inst Canc Res, I-00161 Rome, Italy
来源：
ONCOLOGY | 2009年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
17
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [1] Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
    Hirano, Akira
    Shimizu, Tadao
    Watanabe, Osamu
    Kinoshita, Jun
    Kimura, Kiyomi
    Kamimura, Mari
    Domoto, Kaoru
    Aiba, Motohiko
    Ogawa, Kenji
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4137 - 4142
  • [2] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [3] Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Nisticò, C
    De Matteis, A
    Ross, E
    Carnino, F
    Valenza, R
    Agostara, B
    Bria, E
    Farris, A
    Cremonesi, M
    D'Ottavio, AM
    Vaccaro, A
    Garufi, C
    Giunta, S
    Botti, C
    Perrone, F
    Terzoli, E
    [J]. ANTICANCER RESEARCH, 2005, 25 (2B) : 1343 - 1348
  • [4] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    E. Espinosa
    S. Morales
    P. Borrega
    A. Casas
    C. Madroñal
    I. Machengs
    J. A. Illarramendi
    J. Lizón
    J. A. Moreno
    J. Belón
    J. Janáriz
    M. de la Puente
    T. Checa
    J. R. Mel
    M. González Barón
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 54 : 546 - 552
  • [5] Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Espinosa, E
    Morales, S
    Borrega, P
    Casas, A
    Madroñal, C
    Machengs, I
    Illarramendi, J
    Lizón, J
    Moreno, J
    Belón, J
    Janáriz, J
    de la Puente, M
    Checa, T
    Mel, JR
    Barón, MG
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (06) : 546 - 552
  • [6] The combination of epirubicin plus docetaxel as neoadjuvant chemotherapy in locally-advanced breast cancer
    Hirano, A
    Shimizu, T
    Imamura, H
    Watanabe, O
    Kinoshita, J
    Okabe, T
    Kimura, K
    Kamimura, M
    Domoto, K
    Aiba, M
    Ogawa, K
    [J]. ANTICANCER RESEARCH, 2006, 26 (1B) : 581 - 584
  • [7] Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer
    Kaya, A. O.
    Coskun, U.
    Buyukberber, S.
    Benekli, M.
    Tekin, E.
    Cifter, C.
    Ozturk, B.
    Yildiz, R.
    Yaman, E.
    Uner, A.
    Yamac, D.
    [J]. JOURNAL OF BUON, 2010, 15 (02): : 248 - 254
  • [8] Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
    Won, Hye Sung
    Kim, Yong Seok
    Kim, Jeong Soo
    Chang, Eun Deok
    Na, Sae Jung
    Whang, In Yong
    Lee, Dong Soo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (06): : 1489 - 1496
  • [9] Docetaxel and epirubicin in advanced breast cancer
    Sessa, C
    Pagani, O
    [J]. ONCOLOGIST, 2001, 6 : 13 - 16
  • [10] Primary chemotherapy with sequential docetaxel followed by docetaxel and epirubicin in large operable breast cancer
    Frutuoso, C.
    Henriques, I.
    Pazos, I.
    Abraul, E.
    Pego, A.
    Belo, J.
    Campos, O.
    Gervasio, H.
    De Oliveira, C.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 447 - 450
12345